Analysen von Michael Leuchten

30.01.20 Roche buy UBS AG
10.01.20 Roche buy UBS AG
25.11.19 Roche buy UBS AG
19.11.19 Bayer buy UBS AG
14.11.19 Roche buy UBS AG
11.11.19 Roche buy UBS AG
07.11.19 Roche buy UBS AG
01.11.19 Novo Nordisk buy UBS AG
31.10.19 Bayer buy UBS AG
30.10.19 Bayer buy UBS AG
21.10.19 Novo Nordisk buy UBS AG
16.10.19 Roche buy UBS AG
17.09.19 Roche buy UBS AG
16.09.19 Roche buy UBS AG
05.09.19 Bayer buy UBS AG
02.09.19 Novo Nordisk buy UBS AG
09.08.19 Novo Nordisk buy UBS AG
31.07.19 Bayer buy UBS AG
31.07.19 Novo Nordisk buy UBS AG
30.07.19 Bayer buy UBS AG
26.07.19 Roche buy UBS AG
16.07.19 Bayer buy UBS AG
28.06.19 Bayer buy UBS AG
18.06.19 Novo Nordisk buy UBS AG
11.06.19 Novo Nordisk buy UBS AG
07.05.19 Novo Nordisk buy UBS AG
03.05.19 Novo Nordisk buy UBS AG
25.04.19 Bayer buy UBS AG
28.03.19 Bayer buy UBS AG
07.03.19 Merck buy UBS AG
27.02.19 Bayer buy UBS AG
22.02.19 Bayer buy UBS AG
12.02.19 Bayer buy UBS AG
07.02.19 GSK buy UBS AG
29.01.19 Sartorius vz. buy UBS AG
02.01.19 GSK buy UBS AG
13.12.18 Sartorius vz. buy UBS AG
06.12.18 Bayer buy UBS AG
04.12.18 GSK buy UBS AG
30.11.18 Novo Nordisk buy UBS AG
26.11.18 Novo Nordisk buy UBS AG
13.11.18 Bayer buy UBS AG
05.11.18 Novo Nordisk buy UBS AG
01.11.18 Novo Nordisk buy UBS AG
01.11.18 GSK buy UBS AG
23.10.18 Bayer buy UBS AG
17.10.18 Merck buy UBS AG
11.10.18 Bayer buy UBS AG
10.10.18 Novo Nordisk buy UBS AG
05.10.18 Novo Nordisk buy UBS AG